Neuropace Inc at Needham Healthcare Conference (Virtual) Transcript
Good morning. Thanks for joining us again at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson, and I lead the medtech and diagnostics equity research team at Needham & Company.
I'm pleased to introduce NeuroPace. Presenting from NeuroPace is CEO Mike Favet and CFO Rebecca Kuhn. Mike is going to give a presentation -- Mike and Rebecca, excuse me, are going to give a presentation on NeuroPace. And then we should have some time for questions.
If you do have a question that you would like me to ask, you can submit them electronically through the Needham conference website. Or you could feel free to email them to me at [email protected], and I'll do my best to fit them in.
So with that, I'll turn it over to Mike. Thanks.
Good morning, everyone. Mike, thank you for the opportunity to be able to present this morning. For those of you who haven't been familiar with NeuroPace, I'm going to go over an overview of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
